CNIC researchers discover a new target for the treatment of fatty liver disease

(Centro Nacional de Investigaciones Cardiovasculares) Two proteins, p38 gamma and p38 delta, control the accumulation of fat in the liver, a process linked to the development of insulin resistance and diabetes, which are common outcomes of obesity